02/19/2025
8:45 PM | German Christopher Paul (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
8:46 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
8:47 PM | Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
8:48 PM | Meeker David P (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
8:49 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
8:50 PM | Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
8:44 PM | Garfield Alastair (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
8:43 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
5:36 PM | PRIMECAP MANAGEMENT CO/CA/ (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025
8:46 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
8:47 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for RYTM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Rhythm Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
02/11/2025
8:44 PM | Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
8:45 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
4:30 PM | GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/07/2025
4:05 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
3:20 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/04/2025
8:27 PM | Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
8:22 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
8:23 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
8:25 PM | Meeker David P (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
8:26 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
6:17 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
8:50 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SC 13G | |
11/14/2024
4:46 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/13/2024
8:01 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4/A | |
11/13/2024
8:02 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
8:04 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
4:07 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
7:20 AM | Rhythm Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024
3:02 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
3:49 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
3:30 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
3:42 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
3:30 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:31 PM | Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:32 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
3:31 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024
3:30 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2024
3:31 PM | Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2024
3:31 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
3:26 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Your trading day could end at 11 AM (Ad) What do you usually do between 9:35 AM and 11:00 AM?
Catch up on emails? Attend a meeting? Maybe grab a coffee?
For me, it's become the most important part of my trading day.
85 minutes. That's usually all it takes.
Set up at 9:35 AM… Check back at 11:00 AM.
And when things work out, there's an extra $100 to $150 in my account… on a $1000 starting stake.
Sounds too simple, doesn't it? Tap this link and see the complete breakdown. |
08/26/2024
3:27 PM | Rhythm Pharmaceuticals (Subject)
TETRAULT LYNN A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
3:27 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
3:45 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
3:13 PM | Rhythm Pharmaceuticals (Subject)
TETRAULT LYNN A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
5:00 AM | Rhythm Pharmaceuticals (Filer)
| Form DEFR14A | |
08/07/2024
5:03 AM | Rhythm Pharmaceuticals (Filer)
| Form DEFA14A | |
08/06/2024
6:00 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
4:09 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
4:59 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
3:30 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
3:37 PM | Rhythm Pharmaceuticals (Subject)
Shulman Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
3:34 PM | Rhythm Pharmaceuticals (Subject)
Shulman Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024
4:00 PM | Garfield Alastair (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/10/2024
4:01 PM | Garfield Alastair (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
3:05 PM | Rhythm Pharmaceuticals (Filer)
| Form 424B7 | |
07/10/2024
3:07 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
3:39 PM | MCGIRR DAVID W J (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:41 PM | Arbuckle Stuart A (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:30 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:35 PM | JEAN CHRISTOPHE (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:37 PM | Bedrosian Camille L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:38 PM | Mathers Edward T (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:38 PM | Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
8:44 PM | MCGIRR DAVID W J (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
8:47 PM | Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
8:38 PM | Arbuckle Stuart A (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
8:39 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
8:41 PM | Bedrosian Camille L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
8:42 PM | JEAN CHRISTOPHE (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
8:43 PM | Mathers Edward T (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
4:28 PM | Rhythm Pharmaceuticals (Filer)
| Form DEFA14A | |
06/17/2024
4:19 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
3:43 PM | Rhythm Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
6:10 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2024
6:31 PM | NEW ENTERPRISE ASSOCIATES 13 LP (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SC 13D/A | |
04/26/2024
3:13 PM | Rhythm Pharmaceuticals (Filer)
| Form ARS | |
04/17/2024
3:15 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SC 13D/A | |
04/16/2024
7:11 PM | Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
6:00 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2024
7:00 PM | German Christopher Paul (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
5:18 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SC 13D/A | |
04/01/2024
4:25 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2024
3:55 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:21 PM | Rhythm Pharmaceuticals (Subject)
Shulman Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
4:51 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SC 13D | |
03/20/2024
3:41 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2024
7:50 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:52 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:53 PM | Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:54 PM | Meeker David P (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Why Buffett and 100 members of Congress are Piling into this One Investment (Ad) This isn't just another investment.
It might be the last retirement stock you'll ever need.
But this window of opportunity is closing fast. Click here for the ticker >>> |
03/19/2024
7:56 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:57 PM | Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:58 PM | Rhythm Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/29/2024
3:44 PM | Rhythm Pharmaceuticals (Filer)
| Form 424B5 | |
02/29/2024
3:46 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
3:05 PM | Rhythm Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/22/2024
6:01 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2024
6:00 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
6:00 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free RYTM Stock Alerts